| Macquarie Group Limited (MQG) ORDINARY FULLY PAID |
Financials |
$100,473 |
Notification regarding unquoted securities - MQG
|
30 Jul 2026 10:17AM |
$250.310 |
$261.900 |
risen by
4.63%
|
|
| DataWorks Group Limited (DWG) ORDINARY FULLY PAID |
Information Technology |
$15 |
Appendix 4C & Quarterly Activities Report
|
30 Jul 2026 10:17AM |
$0.120 |
$0.145 |
risen by
20.83%
|
|
DWG - Price-sensitive ASX Announcement
Full Release
Key Points
- Dataworks Group Limited (ASX: DWG) generated positive operating cashflow of approximately $276,000 for FY26, achieving cashflow breakeven.
- The company reported positive operating cashflow of approximately $538,000 during the June quarter.
- Customer cash receipts increased to over $10.3 million during FY26, rising to approximately $11.1 million after including the R&D tax incentive.
- Dataworks launched BetGuard, Ontario's Centralised Self-Exclusion platform, and established a dedicated Toronto-based Contact Centre.
- The company's platforms have processed over 41 billion real-time exclusion checks globally.
- Dataworks completed the largest contract expansion through the Ontario Change Order.
- The company has ongoing strategic interest and engagement with potential partners.
- Dataworks operates two large-scale Centralised Self-Exclusion platforms in Australia and Ontario.
- The financial outlook for the company is strong, with continued growth expected in regulated gambling technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appendix 4C & Activity Report for Q4 FY2026
|
30 Jul 2026 10:17AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
AN1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Anagenics Limited anticipates its first full-year profit for FY2026, subject to audit.
- Operating cash outflow for 4Q26 was $0.08 million.
- Reduction in payables and borrowings from $2 million to $0.2 million.
- BLC Cosmetics successfully restructured and expanding its product range.
- Royalty revenue of $446k from YSB product line in 4Q26.
- Total YSB royalty revenue of $1.3 million for the year ending 30 June 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zenith Minerals Limited (ZNC) ORDINARY FULLY PAID |
Materials |
$58 |
Change in substantial holding from FRS
|
30 Jul 2026 10:16AM |
$0.090 |
$0.090 |
fallen by
0%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$624 |
Change in substantial holding for ZNC
|
30 Jul 2026 10:16AM |
$0.355 |
$0.385 |
risen by
8.45%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
Quarterly Activities & Cashflow Report - June 2026 (Q4FY26)
|
30 Jul 2026 10:12AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Envirostream achieved revenue of A$1.65 million in Q4 FY26.
- Gross profit for the quarter was A$0.64 million, with a gross margin of 39%.
- Livium formalized a recycling services framework with CATL.
- The company launched a Share Purchase Plan to secure funding.
- A strategic alliance and investment discussions are ongoing with a multinational organization.
- Livium completed the relocation of its operations to the Derrimut Hub.
- The company seeks to become cash neutral through cost management and growth in recycling revenues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
Proposed issue of securities - LIT
|
30 Jul 2026 10:07AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
Proposed issue of securities - LIT
|
30 Jul 2026 10:06AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
LIT Secures Initial A$1.575m Institutional Investment & SPP
|
30 Jul 2026 10:06AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Livium secures A$1.575 million initial investment from Lind.
- Potential funding capacity up to A$11.75 million.
- Launch of Share Purchase Plan for additional shareholder investment.
- Funding supports battery recycling and working capital.
- Strategic evaluation of financing options undertaken.
- Funding agreements are unsecured and interest-free.
- Focus on operational efficiency and new recycling opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$9 |
Director Appointment/Resignation
|
30 Jul 2026 10:04AM |
$0.006 |
$0.006 |
fallen by
0%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$169 |
June 2026 Quarterly activity report & Appendix 4C
|
30 Jul 2026 10:03AM |
$0.039 |
$0.046 |
risen by
16.67%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Pivotal XanaMIA phase 2b/3 Alzheimer's disease trial on track for final results in November 2026
- 88% of main trial participants continue in open-label extension phase with Xanamem therapy
- Positive scientific advice from European Medicines Agency aligns with US FDA
- New patents received for Xanamem treatment and manufacturing
- June 2026 cash balance of $16.7 million extends runway beyond trial results to mid-2027
- Continued strong enrolment and progress in XanaMIA trial and open-label extension
- Publication of positive anti-depressant activity of Xanamem in the British Journal of Psychiatry
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kinetiko Energy Limited (KKO) ORDINARY FULLY PAID |
Energy |
$60 |
Proposed issue of securities - KKO
|
30 Jul 2026 10:03AM |
$0.035 |
$0.038 |
risen by
8.57%
|
|
| Kinetiko Energy Limited (KKO) ORDINARY FULLY PAID |
Energy |
$60 |
Completion of $5.4M Placement
|
30 Jul 2026 10:03AM |
$0.035 |
$0.038 |
risen by
8.57%
|
|
KKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Kinetiko Energy Ltd completed a $5.4M placement.
- The placement price was $0.03 per share, a 14% discount.
- Major shareholder Talent 10 Holdings committed $3M.
- Funds will support Phase 1 development and exploration.
- The placement was structured in two tranches, pending shareholder approval.
- Tranche 1 involves 50 million shares, Tranche 2 involves 130 million shares.
- Funds will assist in developing the Brakfontein gas wells aiming for commercial production in 2027.
- Kinetiko plans to secure a new CEO and focus on gas production permitting.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beetaloo Energy Australia Limited (BTL) ORDINARY FULLY PAID |
Energy |
$332 |
BTL Signs Digital Development MOU with Halliburton
|
30 Jul 2026 10:03AM |
$0.220 |
$0.220 |
fallen by
0%
|
|
| Kingsland Minerals Ltd (KNG) ORDINARY FULLY PAID |
Materials |
$6 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 Jul 2026 10:03AM |
$0.069 |
$0.062 |
fallen by
10.14%
|
|
KNG - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed soil sampling at Lake Johnston confirming lithium anomalies.
- High gallium recovery rate at Leliyn Graphite Project.
- Received R&D tax refund of $809,000 post-quarter end.
- End of quarter cash balance at $458,000.
- Continued focus on exploration in Northern Territory and Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,870 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 10:01AM |
$2.010 |
$2.210 |
risen by
9.95%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Ryoncil® net revenue was US$36 million for the quarter.
- Full-year Ryoncil® revenue was US$115 million.
- Net operating cash spend was US$43.8 million for the full year.
- US$103 million of cash held at June 30, 2026.
- Drew US$50 million from a five-year facility to clear debts.
- Expanding Ryoncil® use to adults with SR-aGvHD.
- Achieved target of 300 patients treated in a Phase 3 trial for chronic low back pain.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,599 |
Cleansing Notice
|
30 Jul 2026 10:00AM |
$0.260 |
$0.310 |
risen by
19.23%
|
|
| Environmental Clean Technologies Limited (ECT) ORDINARY FULLY PAID |
Industrials |
$43 |
Continuation of Suspension from Quotation
|
30 Jul 2026 10:00AM |
$0.135 |
$0.120 |
fallen by
11.11%
|
|
ECT - Price-sensitive ASX Announcement
Full Release
Key Points
- Environmental Clean Technologies Limited (ASX: ECT) has been suspended from quotation.
- The suspension was requested by ECT pending an announcement regarding a potential acquisition and an ASX price query response.
- Voluntary suspension was initially granted until 30 July 2026.
- As of 30 July 2026, ECT is not ready to release an announcement that would enable reinstatement of its securities.
- Securities remain suspended in accordance with Listing Rule 17.3.
- Suspension continues until ASX is satisfied with ECT's compliance with Listing Rules, including Listing Rule 3.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,599 |
Application for quotation of securities - EQR
|
30 Jul 2026 10:00AM |
$0.260 |
$0.310 |
risen by
19.23%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$119 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
30 Jul 2026 10:00AM |
$0.510 |
$0.545 |
risen by
6.86%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive FDA End-of-Phase 2 meeting for ATH434.
- Planned initiation of Phase 3 trial by end of 2026.
- Received A$3.98 million R&D Tax Incentive refund.
- Cash balance of A$37.3 million as of June 30, 2026.
- Strategic funding and partnership evaluations ongoing.
- Ms Ann Cunningham appointed to Board of Directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$38 |
Investor Briefing Webinar - Amended
|
30 Jul 2026 9:59AM |
$0.105 |
$0.130 |
risen by
23.81%
|
|
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$23 |
Proposed issue of securities - LML
|
30 Jul 2026 9:59AM |
$0.012 |
$0.008 |
fallen by
33.33%
|
|
| SRG Global Limited (SRG) ORDINARY FULLY PAID |
Industrials |
$2,281 |
Advance Notice - Full Year Results Investor Briefing
|
30 Jul 2026 9:59AM |
$3.340 |
$3.640 |
risen by
8.98%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$43 |
Cleansing Notice
|
30 Jul 2026 9:59AM |
$0.016 |
$0.018 |
risen by
12.50%
|
|
| RAS Technology Holdings Limited (RTH) ORDINARY FULLY PAID |
Industrials |
$33 |
Tabcorp signs new agreement for Data and Content
|
30 Jul 2026 9:58AM |
$0.580 |
$0.680 |
risen by
17.24%
|
|
RTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Tabcorp signs new four-year agreement with RAS Technology Holdings Limited to provide domestic data and content.
- Contract value over the term is $9.1 million plus indexation.
- The agreement expands to include RAS's Fast Form service.
- RAS supplies market-leading data, analytics, and predictive models to Tabcorp.
- RAS and Tabcorp have a relationship spanning over 15 years.
- Either party can terminate the agreement on specific conditions with a 30-day notice.
- RAS retains the right to license the same data to other parties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.